Cue Biopharma, Inc. (CUE)
0.31
+0.01
(+2.99%)
USD |
NASDAQ |
Mar 10, 16:00
0.3117
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma EPS Diluted (Quarterly) : -0.0738 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.448M |
| Revenue (Quarterly) | 2.149M |
| Total Expenses (Quarterly) | 9.597M |
| Enterprise Value | 15.78M |
| Gross Profit Margin (Quarterly) | 96.32% |
| Profit Margin (Quarterly) | -346.6% |
| Earnings Yield | -147.0% |
| Normalized Earnings Yield | -147.00 |